Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	costamere	ANK3 CMYA5 SVIL DMD	1.02e-05	22	132	4	GO:0043034
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	HBS1L MAP7D3 KIF26B TEX2 PPFIBP1 UBE2O PTPN12 PLEKHA5 CEP152 ASCC3 SNX2	6.62e-10	209	135	11	36779422
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	STIM2 ANK3 KIF26B PPFIBP1 DOCK9 PARD3B MSN C2CD2L PHLDB1 NF1 CPNE3 PLEKHA5 DMD	3.09e-09	377	135	13	38117590
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	USP34 NEBL TEX2 VPS13C ITSN1 HUWE1 C2CD2L YEATS2 UBE2O NFRKB ZNF638 PLEKHA5 MPHOSPH9 EXOC7 ESPL1 IQCG	2.91e-08	733	135	16	34672954
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	STIM2 MAP7D3 KIF26B TEX2 PPFIBP1 PARD3B FSIP2 PHLDB1 NF1 SLF2 SVIL BUB1B PLEKHA5 CEP152 MPHOSPH9 TMEM102 SNX2	4.45e-08	861	135	17	36931259
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ITSN1 HUWE1 ECPAS MED24 YEATS2 NCOR1 NF1 SVIL NFRKB MKI67 ZNF638 TLN2 ATM ESPL1 SNX2 SON	6.13e-08	774	135	16	15302935
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	STIM2 MAP7D3 ANK3 AHCTF1 ITSN1 UBE2O SVIL MKI67 ZNF638 PLEKHA5	8.86e-08	263	135	10	34702444
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	USP34 HBS1L ZBTB6 AOC1 ANK3 TEX2 DOCK9 AHCTF1 ITSN1 HUWE1 MED24 KCNJ3 PLCL2 NFRKB CPNE3 PAN2 ZNF638 ESPL1	2.29e-07	1084	135	18	11544199
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	HBS1L MAP7D3 ANK3 AHCTF1 HUWE1 YEATS2 NCOR1 UBE2O BUB1B NFRKB PLEKHA5 ASCC3 SNX2	2.49e-07	549	135	13	38280479
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	USP34 PPFIBP1 SYNE1 DOCK9 C2CD2L ZNF462 PHLDB1 PLEKHA5 TLN2	2.61e-07	225	135	9	12168954
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	USP34 STIM2 MAP7D3 ANK3 PPFIBP1 VPS13C MUC16 HUWE1 CDKL5 NCOR1 MKI67 ZNF638 ZFHX3 MPHOSPH9 CDON	3.88e-07	777	135	15	35844135
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	MAP7D3 YEATS2 NCOR1 SVIL BUB1B NFRKB MKI67 CEP152	6.58e-07	184	135	8	32908313
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	AHCTF1 HUWE1 NCOR1 PTPN12 MKI67 PAN2 ZNF638 PLEKHA5 TLN2 EXOC7 SNX2 SON	6.81e-07	503	135	12	16964243
Pubmed	Overlapping Activities of Two Neuronal Splicing Factors Switch the GABA Effect from Excitatory to Inhibitory by Regulating REST.	USP34 ANK3 VPS13C DOCK9 MKI67 ATP2B2 SNX2	7.26e-07	128	135	7	30995482
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	USP34 HUWE1 ECPAS ZNF462 YEATS2 NCOR1 CEP44 BUB1B PLEKHA5 ZFHX3 ASCC3	7.82e-07	418	135	11	34709266
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	HBS1L MAP7D3 PPFIBP1 VPS13C ITSN1 PARD3B CNTLN ECPAS NCOR1 SVIL BUB1B CPNE3 CEP152 MPHOSPH9 SNX2	1.24e-06	853	135	15	28718761
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ZNF704 ANK3 VPS13C ADGRL1 CHD9 PARD3B HUWE1 COG3 ECPAS GMPS ZNF462 YEATS2 PHLDB1 KCNJ3 KIAA1328 EXOC6B ZNF638 ZFHX3 PNPLA7 SNX2	1.30e-06	1489	135	20	28611215
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	USP34 AHCTF1 HUWE1 ECPAS MSN GMPS UBE2O NF1 MKI67 ZNF638 ATM ASCC3 SON	1.73e-06	653	135	13	22586326
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	STIM2 ANK3 TEX2 DOCK9 ADGRL1 HMGCL HUWE1 UFM1 MSN C2CD2L GMPS CDKL5 UBE2O NF1 KCNJ3 TLN2 FAM131B	2.18e-06	1139	135	17	36417873
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	USP34 ECPAS GMPS ZNF462 NCOR1 CPNE3 ZFHX3 SON	2.51e-06	220	135	8	35785414
Pubmed	A human MAP kinase interactome.	ANK3 KIF26B SYNE1 ITSN1 ADGRL1 KIAA1328 PLEKHA5 NKTR MPHOSPH9 KIF5A DMD	3.35e-06	486	135	11	20936779
Pubmed	Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	HBS1L DOCK9 NCOR1 PLCL2 EXOC7 SON	3.40e-06	104	135	6	10470851
Pubmed	An investigation into the human serum "interactome".	GARIN5B ABCA6 CEP44 TLN2 ATM DMD DNTT	3.51e-06	162	135	7	15174051
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	HBS1L STIM2 MAP7D3 ANK3 PPFIBP1 AHCTF1 ECPAS MSN GMPS BUB1B PLEKHA5 MPHOSPH9 ASCC3	4.16e-06	708	135	13	39231216
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	HBS1L MYO9B AHCTF1 SNX17 HUWE1 HIRA MSN GMPS PHLDB1 PTPN12 NF1 ARAP3 CPNE3 MKI67 ZNF638 PLEKHA5 ASCC3 SON	5.30e-06	1353	135	18	29467282
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ANK3 SYNE1 ITSN1 HUWE1 CYRIB HIRA MSN ZNF462 NCOR1 UBE2O NF1 SVIL PLEKHA5 TLN2 KIF5A	5.42e-06	963	135	15	28671696
Pubmed	A proteomic analysis of ataxia telangiectasia-mutated (ATM)/ATM-Rad3-related (ATR) substrates identifies the ubiquitin-proteasome system as a regulator for DNA damage checkpoints.	USP34 HUWE1 ATM	6.73e-06	10	135	3	17478428
Pubmed	Sonic hedgehog signaling regulates actin cytoskeleton via Tiam1-Rac1 cascade during spine formation.	ITSN1 CDKL5 SCAPER	9.22e-06	11	135	3	20654717
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ANK3 SYNE1 ITSN1 ADGRL1 CYRIB LACTB CDKL5 CRACD PHLDB1 UBE2O NF1 SVIL SCAPER PLEKHA5 TLN2 DMD ATP2B2 SNX2	1.13e-05	1431	135	18	37142655
Pubmed	Cholesterol loss during glutamate-mediated excitotoxicity.	STIM2 CYP46A1	1.50e-05	2	135	2	22343944
Pubmed	NF1 patient missense variants predict a role for ATM in modifying neurofibroma initiation.	NF1 ATM	1.50e-05	2	135	2	31664505
Pubmed	Ubiquitin-specific protease 34 in macrophages limits CD8 T cell-mediated onset of vitiligo in mice.	USP34 ATM	1.50e-05	2	135	2	37043976
Pubmed	Atbf1 is required for the Pit1 gene early activation.	POMC MKI67 ZFHX3	1.59e-05	13	135	3	18272476
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	MAP7D3 NEBL AHCTF1 GMPS YEATS2 CRACD UBE2O PTPN12 CEP44 BUB1B CPNE3 MKI67 ZNF638 SON	1.74e-05	934	135	14	33916271
Pubmed	Transcriptome of the inner circular smooth muscle of the developing mouse intestine: Evidence for regulation of visceral smooth muscle genes by the hedgehog target gene, cJun.	ZBTB6 ITIH5 NF1 NKD1 SVIL FOXF2	1.87e-05	140	135	6	26930384
Pubmed	Functional proteomics mapping of a human signaling pathway.	STIM2 ZBTB6 ANK3 ITSN1 SNX17 HUWE1 NCOR1 PTPN12 PLCL2 ASCC3 SON	2.08e-05	591	135	11	15231748
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	COL5A2 ANK3 DOCK9 CHD9 ECPAS PHLDB1 TRANK1 PLEKHA5 ATM ASCC3	2.60e-05	497	135	10	36774506
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	USP34 HUWE1 ECPAS GMPS UBE2O PTPN12 ARAP3 CPNE3 KIF5A DMD ASCC3 ESPL1 ZNF548 SNX2	2.75e-05	974	135	14	28675297
Pubmed	Scanning the human proteome for calmodulin-binding proteins.	STIM2 HUWE1 LACTB SLF2 SCAPER	3.07e-05	92	135	5	15840729
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SYNE1 DOCK9 ADGRL1 C2CD2L YEATS2 CRACD PHLDB1 PLCL2 SON	3.22e-05	407	135	9	12693553
Pubmed	A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.	ANK3 NEBL ODAD2 ITIH5 SLF2 SVIL MKI67 GSTO1 DNTT	3.74e-05	415	135	9	16385451
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	TEX2 VPS13C SYNE1 CASP10 ECPAS MSN GMPS MED24 PHLDB1 MKI67 ZNF638 DMD	4.02e-05	754	135	12	35906200
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP34 TEX2 VPS13C SNX17 ECPAS UBE2O TRANK1 PAN2 PLEKHA5 ESPL1	4.39e-05	529	135	10	14621295
Pubmed	Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models.	MUC16 MKI67	4.48e-05	3	135	2	27163153
Pubmed	Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agents.	BUB1B ATM	4.48e-05	3	135	2	34545188
Pubmed	Association of Cell Adhesion Molecules Contactin-6 and Latrophilin-1 Regulates Neuronal Apoptosis.	ADGRL1 CNTN6	4.48e-05	3	135	2	28018171
Pubmed	Three-dimensional mapping reveals heterochronic development of the neuromuscular system in postnatal mouse skeletal muscles.	MKI67 DMD	4.48e-05	3	135	2	36347940
Pubmed	Association of terminal deoxynucleotidyl transferase with Ku.	MKI67 DNTT	4.48e-05	3	135	2	10570175
Pubmed	Foxf2 and Smad6 co-regulation of collagen 5A2 transcription is involved in the pathogenesis of intrauterine adhesion.	COL5A2 FOXF2	4.48e-05	3	135	2	32022446
Pubmed	USP52 regulates DNA end resection and chemosensitivity through removing inhibitory ubiquitination from CtIP.	PAN2 ATM	4.48e-05	3	135	2	33097710
Pubmed	Archvillin, a muscle-specific isoform of supervillin, is an early expressed component of the costameric membrane skeleton.	SVIL DMD	4.48e-05	3	135	2	12711699
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	MAP7D3 HUWE1 HIRA MED24 UBE2O BUB1B ZNF638 CEP152 MPHOSPH9 KIF5A GSTO1	4.60e-05	645	135	11	25281560
Pubmed	Proximity interactions among centrosome components identify regulators of centriole duplication.	MAP7D3 UBE2O CEP152 NKTR MPHOSPH9	4.81e-05	101	135	5	24613305
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	COL5A2 MYO9B AHCTF1 ITSN1 HUWE1 YEATS2 SVIL SON	4.91e-05	332	135	8	37433992
Pubmed	Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.	SYNE1 AHCTF1 HUWE1 SVIL MKI67 ZNF638 ASCC3 SON	4.91e-05	332	135	8	25693804
Pubmed	Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	TEX2 SYNE1 UBE2O CEP44 PLEKHA5	5.04e-05	102	135	5	11214970
Pubmed	Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder.	GARNL3 ANK3 SYNE1	5.30e-05	19	135	3	18711365
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	CHD9 HUWE1 ECPAS TRANK1 TLN2	5.53e-05	104	135	5	9205841
Pubmed	The DNA sequence and analysis of human chromosome 13.	DOCK9 CCDC168 COG3 UFM1 LPAR6 SLITRK6	5.57e-05	170	135	6	15057823
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	MAP7D3 ANK3 PPFIBP1 UFM1 NF1 CEP44 PLCL2 CPNE3 EXOC6B PAN2 ZNF638 PLEKHA5 NKTR TMEM102 EXOC7 ATP2B2	5.66e-05	1321	135	16	27173435
Pubmed	Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.	ANK3 TEX2 PPFIBP1 CEP44 PLEKHA5 CEP152 MPHOSPH9	5.92e-05	251	135	7	29778605
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	TEX2 DOCK9 ITSN1 SNX17 ADGRL1 C2CD2L NF1 ATP2B2	6.69e-05	347	135	8	17114649
Pubmed	Programmed cell senescence during mammalian embryonic development.	NKD1 MKI67 ATM	7.23e-05	21	135	3	24238962
Pubmed	Genetic variants associated with breast size also influence breast cancer risk.	SNX17 GCKR ZNF277 CDON	7.31e-05	57	135	4	22747683
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	STIM2 PPFIBP1 DOCK9 SNX17 CDKL5 PHLDB1 NF1 PLEKHA5 SLITRK6 IQCG	8.04e-05	569	135	10	30639242
Pubmed	DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation.	SYNE1 ITSN1 CCDC141	8.34e-05	22	135	3	12812986
Pubmed	Mesocortical Dopamine Phenotypes in Mice Lacking the Sonic Hedgehog Receptor Cdon.	MKI67 CDON	8.93e-05	4	135	2	27419218
Pubmed	Ankyrin-G regulates neurogenesis and Wnt signaling by altering the subcellular localization of β-catenin.	ANK3 MKI67	8.93e-05	4	135	2	24821222
Pubmed	Coordinated changes in cellular behavior ensure the lifelong maintenance of the hippocampal stem cell population.	HUWE1 MKI67	8.93e-05	4	135	2	33581058
Pubmed	Genetic variants in GCKR, GIPR, ADCY5 and VPS13C and the risk of severe sulfonylurea-induced hypoglycaemia in patients with type 2 diabetes.	VPS13C GCKR	8.93e-05	4	135	2	22956255
Pubmed	Effects of genetic variants in ADCY5, GIPR, GCKR and VPS13C on early impairment of glucose and insulin metabolism in children.	VPS13C GCKR	8.93e-05	4	135	2	21789219
Pubmed	The ZFHX3 (ATBF1) transcription factor induces PDGFRB, which activates ATM in the cytoplasm to protect cerebellar neurons from oxidative stress.	ZFHX3 ATM	8.93e-05	4	135	2	20876357
Pubmed	Beta-dystrobrevin interacts directly with kinesin heavy chain in brain.	KIF5A DMD	8.93e-05	4	135	2	14600269
Pubmed	Role of PROP1 in pituitary gland growth.	POMC MKI67	8.93e-05	4	135	2	15591534
Pubmed	Low levels of endogenous or X-ray-induced DNA double-strand breaks activate apoptosis in adult neural stem cells.	MKI67 ATM	8.93e-05	4	135	2	26303202
Pubmed	ATM and SIRT6/SNF2H Mediate Transient H2AX Stabilization When DSBs Form by Blocking HUWE1 to Allow Efficient γH2AX Foci Formation.	HUWE1 ATM	8.93e-05	4	135	2	26711340
Pubmed	Deregulated protein kinase A signaling and myospryn expression in muscular dystrophy.	CMYA5 DMD	8.93e-05	4	135	2	18252718
Pubmed	Loss of β2-spectrin prevents cardiomyocyte differentiation and heart development.	MKI67 DMD	8.93e-05	4	135	2	24064296
Pubmed	Gamma-sarcoglycan is required for the response of archvillin to mechanical stimulation in skeletal muscle.	SVIL DMD	8.93e-05	4	135	2	25605665
Pubmed	Disruption of the NHR4 domain structure in AML1-ETO abrogates SON binding and promotes leukemogenesis.	NCOR1 SON	8.93e-05	4	135	2	18952841
Pubmed	MRE11 UFMylation promotes ATM activation.	UFM1 ATM	8.93e-05	4	135	2	30783677
Pubmed	Elevated Expression of Moesin in Muscular Dystrophies.	MSN DMD	8.93e-05	4	135	2	28082118
Pubmed	The E3 ubiquitin ligase Mule acts through the ATM-p53 axis to maintain B lymphocyte homeostasis.	HUWE1 ATM	8.93e-05	4	135	2	22213803
Pubmed	XRRA1 Targets ATM/CHK1/2-Mediated DNA Repair in Colorectal Cancer.	XRRA1 ATM	8.93e-05	4	135	2	29082250
Pubmed	A protein interaction network for Ecm29 links the 26 S proteasome to molecular motors and endosomal components.	SYNE1 ECPAS MKI67 CEP152	8.94e-05	60	135	4	20682791
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	AHCTF1 PARD3B HUWE1 CCDC141 ZNF462 PTPN12 CEP44 ZNF638 ASCC3	9.54e-05	469	135	9	27634302
Pubmed	Role of FEN1 S187 phosphorylation in counteracting oxygen-induced stress and regulating postnatal heart development.	BUB1B MKI67 ATM ESPL1	9.54e-05	61	135	4	27694478
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	HUWE1 GMPS NF1 BUB1B CPNE3 ZNF638 TLN2 ATM EXOC7 SNX2	9.68e-05	582	135	10	20467437
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	USP34 MYO9B ITSN1 CNTLN HUWE1 YEATS2 NCOR1 SLF2 CEP44 CPNE3	1.05e-04	588	135	10	38580884
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	MAP7D3 MYO9B SNX17 HUWE1 ECPAS LACTB HIRA CRACD NCOR1 NFIL3 SNX2 FOXF2	1.35e-04	857	135	12	25609649
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	USP34 ANK3 PPFIBP1 SYNE1 ITSN1 CHD9 HUWE1 CMYA5 UBASH3A UBE2O SLF2 TLN2 KIF5A ATM EXOC7	1.47e-04	1285	135	15	35914814
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	SYNE1 DOCK9 CMYA5 CCDC141 MSN ZNF462 NCOR1 NFIL3 SON	1.47e-04	497	135	9	23414517
Pubmed	Piezo1 regulates the regenerative capacity of skeletal muscles via orchestration of stem cell morphological states.	MKI67 DMD	1.48e-04	5	135	2	35302846
Pubmed	An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan.	ANK3 DMD	1.48e-04	5	135	2	19109891
Pubmed	Tal, a Tsg101-specific E3 ubiquitin ligase, regulates receptor endocytosis and retrovirus budding.	ITSN1 KIF5A	1.48e-04	5	135	2	15256501
Pubmed	Adult pituitary cell maintenance: lineage-specific contribution of self-duplication.	POMC MKI67	1.48e-04	5	135	2	23754801
Pubmed	Activin A, a product of fetal Leydig cells, is a unique paracrine regulator of Sertoli cell proliferation and fetal testis cord expansion.	MKI67 PLEKHA5	1.48e-04	5	135	2	20498064
Pubmed	Matrin-3 is essential for fibroblast growth factor 2-dependent maintenance of neural stem cells.	MKI67 ATM	1.48e-04	5	135	2	30194346
Pubmed	Ataxia telangiectasia mutated-dependent apoptosis after genotoxic stress in the developing nervous system is determined by cellular differentiation status.	MKI67 ATM	1.48e-04	5	135	2	11517258
Pubmed	5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia.	COG3 NF1 ATM	1.56e-04	27	135	3	23027611
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	USP34 CHD9 ECPAS UFM1 MSN GMPS MED24 NCOR1 CPNE3 MKI67 ATM METTL16 SON	1.68e-04	1014	135	13	32416067
Interaction	MCAM interactions	STIM2 ANK3 KIF26B PPFIBP1 DOCK9 PARD3B MSN C2CD2L PHLDB1 NF1 CPNE3 PLEKHA5 DMD	1.49e-05	468	134	13	int:MCAM
Interaction	NUP43 interactions	USP34 AHCTF1 CHD9 CCDC168 ZNF462 FSIP2 YEATS2 NCOR1 SLF2 BUB1B NFRKB MKI67 ZFHX3 NKTR SON	1.81e-05	625	134	15	int:NUP43
Interaction	GSK3B interactions	HBS1L MAP7D3 KIF26B TEX2 PPFIBP1 UFM1 MSN GMPS MED24 UBE2O PTPN12 CPNE3 MKI67 PLEKHA5 CEP152 ASCC3 SNX2 IQCG	1.81e-05	868	134	18	int:GSK3B
Interaction	YWHAZ interactions	STIM2 MAP7D3 KIF26B TEX2 PPFIBP1 DOCK9 PARD3B GCKR HUWE1 MSN FSIP2 CRACD NCOR1 PHLDB1 NF1 SVIL ZNF638 PLEKHA5 MPHOSPH9 KIF5A TMEM102 ATM ATP2B2	1.88e-05	1319	134	23	int:YWHAZ
Interaction	EPHA1 interactions	USP34 SYNE1 CASP10 HUWE1 NF1 MKI67 EXOC6B PLEKHA5 EXOC7	2.82e-05	235	134	9	int:EPHA1
Interaction	YWHAH interactions	STIM2 MAP7D3 KIF26B TEX2 PPFIBP1 DOCK9 PARD3B HUWE1 PHLDB1 NF1 SLF2 SVIL ZNF638 PLEKHA5 CEP152 NKTR MPHOSPH9 KIF5A TMEM102 SNX2	4.05e-05	1102	134	20	int:YWHAH
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	USP34 COL5A2 MYO9B DOCK9 AHCTF1 ITSN1 CHD9 HIRA GMPS PTPN12 BUB1B ZNF638 ZFHX3 MPHOSPH9 DMD ASCC3 SNX2 SON	3.92e-07	856	134	18	M4500
Coexpression	GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN	CHD9 CCDC141 NCOR1 PHLDB1 NFRKB SCAPER PAN2 SON	2.31e-06	166	134	8	M6826
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	MYO9B VPS13C YEATS2 NCOR1 NF1 ATM ESPL1	4.04e-05	180	134	7	M8239
Coexpression	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	ZNF704 ANK3 CMYA5 CYRIB CDKL5 PHLDB1 PTPN12 ZNF277 KCNJ3 EXOC6B FAM131B	5.85e-05	504	134	11	M2157
Coexpression	ZHAN_MULTIPLE_MYELOMA_MF_DN	DOCK9 ITSN1 TRANK1 SCAPER	6.90e-05	43	134	4	M513
Coexpression	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN	USP34 PRTG RGS5 TEX2 VPS13C CHD9 HIRA CDKL5 NCOR1 NF1 ZFHX3 NKTR DMD CDON	6.92e-05	807	134	14	M16651
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	DOCK9 ZFHX3 MPHOSPH9 DMD SON	7.24e-05	84	134	5	M13008
Coexpression	GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN	ADGRL1 ZC3H12B MYLK4 NFRKB EXOC6B ZNF638 NKTR	7.61e-05	199	134	7	M8606
Coexpression	GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_DN	NFIL3 CEP44 LPAR6 EXOC6B PAN2 MPHOSPH9 ESPL1	7.86e-05	200	134	7	M8048
Coexpression	GSE17721_CTRL_VS_CPG_2H_BMDC_UP	HMGCL MSN NCOR1 SLF2 SVIL MPHOSPH9 ATM	7.86e-05	200	134	7	M3759
Coexpression	GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_UP	PPFIBP1 TEX15 UFM1 MSN ZNF277 PLCL2 ZNF638	7.86e-05	200	134	7	M7352
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	ANK3 NEBL PPFIBP1 CMYA5 CCDC141 SVIL PLCL2 EXOC6B PLEKHA5 DMD	3.55e-10	190	135	10	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C CHD9 HTRA3 ITIH5 ABCA6 SLF2 SCN7A PLEKHA5 TLN2 NKTR	3.73e-10	191	135	10	7d1595e616f6f111fc2f5bc1b179c5d67d624cc9
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	NEBL PPFIBP1 CMYA5 CCDC141 SVIL PLCL2 EXOC6B PLEKHA5 DMD	6.67e-09	189	135	9	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	ANK3 NEBL CMYA5 CCDC141 SVIL PLCL2 EXOC6B PLEKHA5 DMD	7.31e-09	191	135	9	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	COL5A2 NEBL KIF26B PARD3B ITIH5 NKD1 ABCA6 SCN7A PLEKHA5	8.76e-09	195	135	9	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C CHD9 CMYA5 ITIH5 ABCA6 SCN7A PLEKHA5 NKTR ASCC3	8.76e-09	195	135	9	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C CHD9 HTRA3 CMYA5 KCNJ3 ZNF638 DMD ASCC3	6.78e-08	176	135	8	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	Control-Fibroblasts-Airway_smooth_muscle\|Control / group, cell type (main and fine annotations)	COL5A2 GARNL3 RGS5 NKD1 SVIL TLN2 ZFHX3 DMD	8.07e-08	180	135	8	d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	ANK3 NEBL CMYA5 CCDC141 SVIL EXOC6B PLEKHA5 DMD	9.56e-08	184	135	8	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	ANK3 NEBL PPFIBP1 CMYA5 CCDC141 EXOC6B PLEKHA5 DMD	9.96e-08	185	135	8	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	pdx\|World / Sample and Cell Type and Tumor Cluster (all cells)	KIF26B PARD3B NKD1 SLF2 EXOC6B PLEKHA5 TLN2 MPHOSPH9	1.04e-07	186	135	8	de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCell	pdx-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	KIF26B PARD3B NKD1 SLF2 EXOC6B PLEKHA5 TLN2 MPHOSPH9	1.04e-07	186	135	8	0b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	COL5A2 ITIH5 CRACD PHLDB1 ABCA6 SCN7A TLN2 DMD	1.08e-07	187	135	8	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	NEBL PPFIBP1 CMYA5 CCDC141 PLCL2 EXOC6B PLEKHA5 DMD	1.22e-07	190	135	8	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	Hippocampus-Neuronal\|Hippocampus / BrainAtlas - Mouse McCarroll V32	USP34 ADGRL1 C2CD2L UBE2O TRANK1 CLVS2 KIF5A ATP2B2	1.43e-07	194	135	8	8aeb347b3024354c9505f4f0fddf0b843489dc6b
ToppCell	LA-02._Fibroblast_II\|LA / Chamber and Cluster_Paper	COL5A2 CHD9 PARD3B PHLDB1 ABCA6 SCN7A PLEKHA5 ZFHX3	1.43e-07	194	135	8	234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	ANK3 NEBL CMYA5 CCDC141 SVIL EXOC6B PLEKHA5 DMD	1.49e-07	195	135	8	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COL5A2 NDST4 HTRA3 ITIH5 CRACD ABCA6 SCN7A FOXF2	1.68e-07	198	135	8	300d7cc56207d77168390fa1ffcbcf76767b1b80
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	ANK3 NEBL PARD3B NF1 SCAPER KIAA1328 EXOC6B DMD	1.68e-07	198	135	8	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	COL5A2 USP29 NDST4 HTRA3 ITIH5 ABCA6 SCN7A FOXF2	1.74e-07	199	135	8	e9009eee7f77b9c9917f8e0e723001d9e76eb553
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL5A2 NDST4 HTRA3 ITIH5 ABCA6 SCN7A SLITRK6 FOXF2	1.81e-07	200	135	8	fb53be20392a8309a7393774c774a1b1aec6e676
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 SLC17A3 KIF26B PPFIBP1 ZNF462 PLEKHA5 TLN2	1.63e-06	186	135	7	b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	ANK3 NEBL CMYA5 KCNJ3 SVIL EXOC6B DMD	1.75e-06	188	135	7	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	facs-Heart-LA/RA-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 NEBL CMYA5 CCDC141 CRACD KCNJ3 MYLK4	1.82e-06	189	135	7	a08b2d0fa35ffa510050ecffdc68e1b79bbe1632
ToppCell	facs-Heart-LA/RA\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 NEBL CMYA5 CCDC141 CRACD KCNJ3 MYLK4	1.82e-06	189	135	7	efa913d9c16fc32166b484d92b6449e8a0c59e03
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	ANK3 NEBL STARD7 CMYA5 SVIL EXOC6B DMD	1.82e-06	189	135	7	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	ANK3 NEBL CMYA5 CYRIB SVIL EXOC6B DMD	1.88e-06	190	135	7	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PPFIBP1 CHD9 PLEKHA5 ATM PNPLA7 SNX2 DNTT	1.95e-06	191	135	7	40813c397f533c2f4a6359a77757f736b6d9e07d
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	ANK3 NEBL CMYA5 KCNJ3 SVIL EXOC6B DMD	1.95e-06	191	135	7	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	LV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	COL5A2 CHD9 PHLDB1 ABCA6 SCN7A PLEKHA5 ZFHX3	1.95e-06	191	135	7	d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	COL5A2 CRACD ABCA6 SCN7A PLEKHA5 TLN2 DMD	2.09e-06	193	135	7	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	ANK3 NEBL CMYA5 KCNJ3 SVIL EXOC6B DMD	2.16e-06	194	135	7	c3535f7cc0076653c72db582047cff053c322397
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	COL5A2 CHD9 PARD3B PHLDB1 ABCA6 SCN7A ZFHX3	2.24e-06	195	135	7	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	RA-02._Fibroblast_II\|RA / Chamber and Cluster_Paper	COL5A2 CHD9 PHLDB1 ABCA6 SCN7A TLN2 ZFHX3	2.24e-06	195	135	7	6a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C HUWE1 NCOR1 SCAPER NKTR ASCC3 SON	2.24e-06	195	135	7	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C HUWE1 NCOR1 SCAPER NKTR ASCC3 SON	2.24e-06	195	135	7	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	ANK3 NEBL PARD3B SCAPER KIAA1328 EXOC6B DMD	2.31e-06	196	135	7	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	LPS_IL1RA_TNF\|World / Treatment groups by lineage, cell group, cell type	COL5A2 RGS5 SYNE1 CHD9 ITIH5 ABCA6 SLITRK6	2.39e-06	197	135	7	0a6550dce156fc81f15b1e7830d331ca50d87d06
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	COL5A2 NEBL KIF26B PPFIBP1 CRACD ABCA6 SCN7A	2.39e-06	197	135	7	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL5A2 NDST4 HTRA3 ITIH5 NKD1 ABCA6 SCN7A	2.39e-06	197	135	7	44673c38384453207871d3fd8e8ba9093cc06bc5
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL5A2 MAP7D3 PHLDB1 NKD1 ABCA6 SCN7A FOXF2	2.39e-06	197	135	7	6d0d68d460243a0259ada93ebda40fa7b3088eeb
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	COL5A2 ANK3 NEBL KIF26B CRACD SCN7A PLEKHA5	2.39e-06	197	135	7	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	3'-Broncho-tracheal-Mesenchymal\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL5A2 RGS5 HTRA3 ITIH5 ABCA6 SCN7A FOXF2	2.47e-06	198	135	7	4961a3e9b953679648586afed04869ff36b81820
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	USP34 ANK3 PARD3B NF1 SCAPER EXOC6B DMD	2.56e-06	199	135	7	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	LPS_IL1RA\|World / Treatment groups by lineage, cell group, cell type	DOCK9 LACTB MSN PTPN12 NF1 SVIL ASCC3	2.64e-06	200	135	7	a02fa5b3c4723a6eaa3c685588666c710478dd25
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	RGS5 PPFIBP1 DOCK9 CASP10 MSN PTPN12 NF1	2.64e-06	200	135	7	2d07237022b409c4fac6fcf99b68c8affb3007cd
ToppCell	Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	COL5A2 HTRA3 ITIH5 ABCA6 SCN7A PLEKHA5 FOXF2	2.64e-06	200	135	7	efdf7066b7dd43e35dbc0d2719b75f250cf54af2
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL5A2 SYNE1 NDST4 ITIH5 ABCA6 SCN7A FOXF2	2.64e-06	200	135	7	58b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRTG SLC17A3 USP29 NDST4 CNTN6 MYLK4	5.39e-06	145	135	6	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	Adult-Mesenchymal-myofibroblast_cell-D122\|Adult / Lineage, Cell type, age group and donor	COL5A2 CRACD PHLDB1 ABCA6 SCN7A SLITRK6	8.82e-06	158	135	6	410fa08c9d880d27e80ec939fa5ba5a41dcb31ab
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRTG SLC17A3 USP29 NDST4 CNTN6 MYLK4	1.02e-05	162	135	6	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	droplet-Heart-nan-18m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HTRA3 CYP46A1 ADH7 NKD1 SCN7A ATM	1.17e-05	166	135	6	9adceb746e67e955fd8b3e0984f4eed44b64a270
ToppCell	Adult-Mesenchymal-myofibroblast_cell\|Adult / Lineage, Cell type, age group and donor	COL5A2 CRACD PHLDB1 NKD1 ABCA6 SCN7A	1.21e-05	167	135	6	d584a8548a5317bd9686b3be8246ae6ed568796b
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_1\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	PRTG YEATS2 PHLDB1 NKD1 EXOC6B ZFHX3	1.25e-05	168	135	6	53a982869dbf14f6a948589be9f2f3df3b9a7e97
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEBL NDST4 CMYA5 MSN NKD1 CCNB3	1.34e-05	170	135	6	17bd7fd25a2657cb536ad47e294332920f759e95
ToppCell	facs-Heart-Unknown-3m-Mesenchymal-atrial_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEBL CMYA5 CCDC141 CRACD KCNJ3 MYLK4	1.43e-05	172	135	6	ee8ce9e8c9a6d3ee2be113f77743958005f4b3f0
ToppCell	facs-Heart-Unknown-3m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEBL CMYA5 CCDC141 CRACD KCNJ3 MYLK4	1.43e-05	172	135	6	bd468a7ea6ec832dcf6a816a1e0c03fa0f176dad
ToppCell	droplet-Marrow-nan-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNE1 TEX15 UBE2O TRANK1 CPNE3 ZFHX3	1.43e-05	172	135	6	d354424c1f861b6607dfd63b9724f4c237b30275
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANK3 NEBL PARD3B CCDC141 CNTN6 PLEKHA5	1.48e-05	173	135	6	b799c06a6a5754668e789f70c0c8bc1508568575
ToppCell	5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GARNL3 RGS5 SVIL PLEKHA5 DMD FOXF2	1.68e-05	177	135	6	e65c0568dc5852108e9802273499bc7cf88fafab
ToppCell	PBMC-Severe-cDC_11\|Severe / Compartment, Disease Groups and Clusters	CRACD ZNF320 CPNE3 PLEKHA5 DMD FAM131B	1.74e-05	178	135	6	0667abc05eb2254710b9c648c65b7cfdfe7831b7
ToppCell	facs-Marrow-KLS-24m-Hematologic-MPP_Fraction_B_+_C\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF704 GARIN5B PHLDB1 MKI67 GSTO1 DNTT	1.79e-05	179	135	6	5297f7459b40ca780a1983fecc1bb9c035c7677e
ToppCell	Children_(3_yrs)-Mesenchymal-myofibroblast_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL5A2 NKD1 SCN7A TLN2 SLITRK6 FOXF2	1.85e-05	180	135	6	01f2e5d96016823482f89ba503d007d4bd88eeac
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PRTG STIM2 ANK3 KIF26B KCNJ3 PLCL2	1.91e-05	181	135	6	b7c85fbef3c06d5dc32a2a58f8d3dfabf1d79d9f
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	ANK3 NEBL CMYA5 SVIL EXOC6B DMD	1.97e-05	182	135	6	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL5A2 NDST4 CMYA5 ITIH5 ABCA6 SCN7A	1.97e-05	182	135	6	3dfa9187e9d2bab1d199079d29209c4648220ada
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NEBL PARD3B CMYA5 ITIH5 CRACD NKD1	2.03e-05	183	135	6	eb559ae3ae252d9365c24ef557dd49b78ed6d898
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RGS5 ITIH5 NKD1 SVIL DMD FOXF2	2.03e-05	183	135	6	61a73de857f4ae02dcba3af348f436f602b28ff2
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF26B ODAD2 TRANK1 TLN2 KIF5A DMD	2.09e-05	184	135	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C CHD9 NCOR1 SLF2 ZNF638 ASCC3	2.09e-05	184	135	6	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF26B ODAD2 TRANK1 TLN2 KIF5A DMD	2.09e-05	184	135	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF26B ODAD2 TRANK1 TLN2 KIF5A DMD	2.09e-05	184	135	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NEBL CMYA5 CCDC141 SVIL EXOC6B DMD	2.16e-05	185	135	6	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 RGS5 ZC3H12B TLN2 CCDC183 CDON	2.16e-05	185	135	6	f814ec9d4ade717a0109398e9768d0d66f09317b
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 RGS5 ZC3H12B TLN2 CCDC183 CDON	2.16e-05	185	135	6	40e958511790e84321da5ccf735f9974c06a0263
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 RGS5 ZC3H12B TLN2 CCDC183 CDON	2.16e-05	185	135	6	5f2eeba80aff145e85cfd81e2890a155406badb9
ToppCell	droplet-Lung-LUNG-1m-Myeloid\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYRIB CRACD PTPN12 NFIL3 PNPLA7 GSTO1	2.16e-05	185	135	6	53a5218c1e6eb12daccde3d6e02f337e2586d74c
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZNF704 COL5A2 ADH7 CRACD TLN2 ATP2B2	2.22e-05	186	135	6	c116cc9f41971622264434ebe29d18e719b0ae19
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF704 ANK3 SYNE1 NKD1 DMD SLITRK6	2.36e-05	188	135	6	3177b2c1723268d330d3e9f24f9e24492ace6286
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	USP34 VPS13C AHCTF1 HUWE1 NF1 NKTR	2.36e-05	188	135	6	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	facs-Heart-LA/RA-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEBL CMYA5 CCDC141 CRACD KCNJ3 MYLK4	2.36e-05	188	135	6	90dc0e15798d0b984518ad58c7e416e30aff687a
ToppCell	facs-Heart-LA/RA-3m-Mesenchymal-atrial_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEBL CMYA5 CCDC141 CRACD KCNJ3 MYLK4	2.36e-05	188	135	6	f63dfd076ced81013918363282ae25cbbd8948ae
ToppCell	facs-Heart-LA/RA-3m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEBL CMYA5 CCDC141 CRACD KCNJ3 MYLK4	2.36e-05	188	135	6	0554d542149cef654ff1e5e32dfbffd8990b52bd
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RGS5 ITIH5 NKD1 SVIL DMD FOXF2	2.36e-05	188	135	6	879de94924de978478696fc7838e05a4d795b905
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-myocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RGS5 ITIH5 NKD1 SVIL DMD FOXF2	2.43e-05	189	135	6	ab7ece0a517499b70b7754720d3e434765363af6
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF704 PRTG STIM2 NEBL KIF26B KCNJ3	2.43e-05	189	135	6	8ff3c3232eff9de4b5c9b22ecb82bc509d773f58
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PRTG STIM2 ANK3 KIF26B KCNJ3 PLCL2	2.43e-05	189	135	6	c9565e962a13a7713056ec3dbb1b67d24f9889c7
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 NEBL SYNE1 PARD3B KCNJ3 KIAA1328	2.43e-05	189	135	6	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF704 COL5A2 ITIH5 MSN SCN7A SON	2.51e-05	190	135	6	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PPFIBP1 SYNE1 DOCK9 PHLDB1 ARAP3 MYLK4	2.51e-05	190	135	6	0a351609a72fd638c84b2435782e312ee6a33aac
ToppCell	LV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	COL5A2 CHD9 PHLDB1 ABCA6 SCN7A ZFHX3	2.51e-05	190	135	6	12992ec80a7b4f4f17de693f0719ee061a9918fd
ToppCell	droplet-Heart-nan-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HTRA3 CMYA5 ITIH5 KCNJ3 SCN7A PLEKHA5	2.51e-05	190	135	6	96a92212ea3fb35fa3d0da495e504edc61c71c23
ToppCell	ASK454-Mesenchymal\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	COL5A2 HTRA3 ITIH5 ABCA6 SCN7A FOXF2	2.58e-05	191	135	6	e30ae7a12439f8a79820b13f03e822c1223fd0cb
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PPFIBP1 SYNE1 DOCK9 PHLDB1 ARAP3 MYLK4	2.58e-05	191	135	6	f229abf69a1217194f74b0502486907e07dba989
ToppCell	COVID-19-Myeloid-DC1\|Myeloid / Condition, Lineage and Cell class	GARNL3 ZNF462 CPNE3 PLEKHA5 DMD FAM131B	2.58e-05	191	135	6	4be3c6287965fe3a2f109d26f68bdc2fa393f99b
ToppCell	ASK454-Mesenchymal-Fibroblast\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	COL5A2 HTRA3 ITIH5 ABCA6 SCN7A FOXF2	2.58e-05	191	135	6	1726add3f392a061536b7aff72ba84303f4a0b1f
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	COL5A2 CHD9 PHLDB1 ABCA6 SCN7A ZFHX3	2.58e-05	191	135	6	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEBL CMYA5 CCDC141 CRACD KCNJ3 MYLK4	2.58e-05	191	135	6	97fb4232417a39801e87725755fd16a57c250209
ToppCell	droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEBL CMYA5 CCDC141 CRACD KCNJ3 MYLK4	2.58e-05	191	135	6	64070a309d7e3f6001272409ab9ce206d0e7d73f
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	ZNF704 PARD3B NKD1 ZNF638 PLEKHA5 NKTR	2.66e-05	192	135	6	916fbec1c7ab7969bda711886ac88e877e30c280
Drug	resveratrol; Down 200; 10uM; MCF7; HT_HG-U133A_EA	USP34 HIRA NCOR1 NF1 KCNJ3 BUB1B MKI67 PLEKHA5 MPHOSPH9 ESPL1	9.41e-08	176	134	10	958_DN
Drug	Ursolic acid [77-52-1]; Down 200; 8.8uM; PC3; HT_HG-U133A	NEBL MYO9B ADGRL1 CYRIB NCOR1 LPAR6 SVIL ATM EXOC7	2.39e-06	195	134	9	5825_DN
Drug	Loxapine succinate [27833-64-3]; Down 200; 9uM; MCF7; HT_HG-U133A	ANK3 MYO9B TEX2 ITSN1 CYRIB HIRA CEP152 NKTR ATM	2.50e-06	196	134	9	5293_DN
Drug	Pindolol [13523-86-9]; Up 200; 16.2uM; PC3; HT_HG-U133A	VPS13C USP29 HUWE1 HIRA C2CD2L CEP152 ATM EXOC7 ATP2B2	2.71e-06	198	134	9	4496_UP
Drug	rapamycin; Up 200; 0.1uM; HL60; HG-U133A	NEBL CASP10 ADH7 KCNJ3 SCAPER TLN2 KIF5A SLC24A1 IQCG	2.83e-06	199	134	9	362_UP
Drug	5149715; Up 200; 10uM; MCF7; HT_HG-U133A_EA	ZBTB6 AOC1 NEBL ITSN1 ECPAS KCNJ3 NFRKB SCAPER ATM	2.83e-06	199	134	9	890_UP
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	DOCK9 ITSN1 CHD9 NF1 ZNF277 SVIL BUB1B PLEKHA5	9.11e-06	174	134	8	7530_DN
Drug	Tubocurarine chloride pentahydrate (+) [6989-98-6]; Up 200; 5.2uM; MCF7; HT_HG-U133A	USP34 COL5A2 HIRA ADH7 NF1 KCNJ3 ATM SLC24A1	1.73e-05	190	134	8	2887_UP
Drug	Carbamazepine [298-46-4]; Down 200; 17uM; HL60; HT_HG-U133A	USP34 MAP7D3 CYRIB HIRA NCOR1 PTPN12 NF1 ATM	1.86e-05	192	134	8	1847_DN
Drug	Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A	USP34 ANK3 NEBL CYRIB NF1 SVIL ATM METTL16	1.93e-05	193	134	8	3667_DN
Drug	Remoxipride Hydrochloride [73220-03-8]; Down 200; 9.8uM; HL60; HT_HG-U133A	RGS5 MYO9B SYNE1 C2CD2L ZNF277 ZFHX3 METTL16 EXOC7	1.93e-05	193	134	8	3124_DN
Drug	Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A	DOCK9 ITSN1 CYRIB C2CD2L MED24 YEATS2 ATM EXOC7	2.01e-05	194	134	8	1670_DN
Drug	Pentoxifylline [6493-05-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A	USP34 ITSN1 CYRIB NF1 ATM EXOC7 CDON IQCG	2.01e-05	194	134	8	6021_DN
Drug	Morantel tartrate [26155-31-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A	NEBL CYRIB HIRA PHLDB1 UBE2O CEP152 ATM EXOC7	2.01e-05	194	134	8	1676_DN
Drug	Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A	ADGRL1 CYRIB HIRA C2CD2L YEATS2 NCOR1 SLF2 TLN2	2.08e-05	195	134	8	3409_DN
Drug	Carbarsone [121-59-5]; Up 200; 15.4uM; PC3; HT_HG-U133A	HBS1L MAP7D3 RGS5 HUWE1 ADH7 NF1 CEP152 EXOC7	2.08e-05	195	134	8	3991_UP
Drug	Nabumetone [42924-53-8]; Down 200; 17.6uM; MCF7; HT_HG-U133A	CYRIB HIRA PHLDB1 NF1 TLN2 CEP152 EXOC7 SLC24A1	2.08e-05	195	134	8	5428_DN
Drug	Panthenol (D) [81-13-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A	MYO9B ITSN1 HIRA NF1 NFRKB NKTR MPHOSPH9 EXOC7	2.16e-05	196	134	8	7455_DN
Drug	Suxibuzone [27470-51-5]; Down 200; 9.2uM; PC3; HT_HG-U133A	ANK3 MYO9B ADGRL1 HIRA LPAR6 PAN2 ATM EXOC7	2.16e-05	196	134	8	5806_DN
Drug	5194442; Down 200; 20uM; MCF7; HT_HG-U133A	USP34 MYO9B SVIL TLN2 NKTR METTL16 EXOC7 SNX2	2.24e-05	197	134	8	6558_DN
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; HL60; HT_HG-U133A	USP34 ZBTB6 PTPN12 NFRKB PLEKHA5 MPHOSPH9 EXOC7 SLC24A1	2.24e-05	197	134	8	1322_DN
Drug	Ioxaglic acid [59017-64-0]; Down 200; 3.2uM; MCF7; HT_HG-U133A	HBS1L NEBL NF1 ZNF277 CEP152 ATM METTL16 EXOC7	2.24e-05	197	134	8	3528_DN
Drug	haloperidol; Up 200; 10uM; PC3; HT_HG-U133A	ZBTB6 CNTLN HIRA NFRKB SCAPER METTL16 ATP2B2 CDON	2.32e-05	198	134	8	1203_UP
Drug	Karakoline [39089-30-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A	COL5A2 HBS1L PHLDB1 NF1 KCNJ3 KIF5A ATP2B2 CDON	2.32e-05	198	134	8	3638_UP
Drug	0175029-0000 [211245-78-2]; Up 200; 10uM; PC3; HT_HG-U133A	MAP7D3 DOCK9 USP29 CASP10 HUWE1 ECPAS PLCL2 FOXF2	2.32e-05	198	134	8	3691_UP
Drug	Thimerosal	USP34 HBS1L STIM2 PPFIBP1 USP29 POMC CHD9 PARD3B COG3 MSN FSIP2 PTPN12 NF1 ARAP3 CPNE3 PLEKHA5 ATM CCDC183 SNX2 SON	2.40e-05	1199	134	20	ctd:D013849
Drug	Naftopidil dihydrochloride [57149-08-3]; Up 200; 8.6uM; PC3; HT_HG-U133A	CASP10 NF1 KCNJ3 PLCL2 SCAPER DMD SLC24A1 IQCG	2.41e-05	199	134	8	4193_UP
Drug	Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A	HBS1L DOCK9 ECPAS HIRA PHLDB1 NF1 KCNJ3 NKTR	2.41e-05	199	134	8	4765_DN
Drug	Trimethadione [127-48-0]; Up 200; 28uM; PC3; HT_HG-U133A	HBS1L TEX15 C2CD2L ADH7 NF1 SCAPER ZFHX3 CEP152	2.50e-05	200	134	8	4086_UP
Drug	torcetrapib	ZNF704 ANK3 PPFIBP1 VPS13C AHCTF1 CHD9 CYREN ZNF277 NFIL3 METTL16	3.60e-05	342	134	10	ctd:C483909
Drug	Crotamiton [483-63-6]; Down 200; 19.6uM; MCF7; HT_HG-U133A	USP34 CYRIB PTPN12 KCNJ3 NFRKB ATM METTL16	9.36e-05	179	134	7	3388_DN
Drug	pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A	USP34 COL5A2 ANK3 SYNE1 HIRA SLF2 SLC24A1	1.07e-04	183	134	7	7088_DN
Drug	Dobutamine hydrochloride [49745-95-1]; Up 200; 11.8uM; PC3; HT_HG-U133A	HBS1L TEX15 HUWE1 PHLDB1 TRANK1 NF1 SCAPER	1.15e-04	185	134	7	6286_UP
Drug	Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; HL60; HT_HG-U133A	USP34 HBS1L CYRIB PTPN12 NF1 ATM EXOC7	1.27e-04	188	134	7	1865_DN
Drug	Muramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; PC3; HT_HG-U133A	DOCK9 ITSN1 CYRIB PHLDB1 ATM FAM131B CDON	1.36e-04	190	134	7	4582_DN
Drug	Imipenem [74431-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A	USP34 ZBTB6 MAP7D3 CYRIB SCAPER TLN2 ATM	1.45e-04	192	134	7	2873_DN
Drug	Cimetidine [51481-61-9]; Down 200; 15.8uM; MCF7; HT_HG-U133A	ZBTB6 MYO9B ADH7 NF1 ZNF277 METTL16 EXOC7	1.45e-04	192	134	7	4144_DN
Drug	Clotrimazole [23593-75-1]; Up 200; 11.6uM; MCF7; HT_HG-U133A	COL5A2 HBS1L USP29 C2CD2L ADH7 SCAPER CEP152	1.49e-04	193	134	7	3166_UP
Drug	Pyrithyldione [77-04-3]; Down 200; 24uM; PC3; HT_HG-U133A	HIRA C2CD2L NCOR1 NF1 LPAR6 METTL16 IQCG	1.49e-04	193	134	7	7153_DN
Drug	Clemastine fumarate [14976-57-9]; Up 200; 8.6uM; HL60; HT_HG-U133A	COL5A2 ZBTB6 ANK3 NEBL CASP10 TEX15 ADH7	1.49e-04	193	134	7	2412_UP
Drug	Clozapine [5786-21-0]; Up 200; 12.2uM; PC3; HT_HG-U133A	DOCK9 CASP10 HUWE1 SCAPER EXOC7 SLC24A1 FAM131B	1.49e-04	193	134	7	4670_UP
Drug	Calycanthine [595-05-1]; Up 200; 11.6uM; MCF7; HT_HG-U133A	SYNE1 ADGRL1 TEX15 NF1 SCAPER ATP2B2 CDON	1.49e-04	193	134	7	2764_UP
Drug	Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; HL60; HG-U133A	USP34 HBS1L ECPAS PTPN12 ZNF277 LPAR6 CEP152	1.54e-04	194	134	7	1413_UP
Drug	Resveratrol [501-36-0]; Down 200; 17.6uM; HL60; HG-U133A	CHD9 CYRIB NCOR1 SLF2 LPAR6 BUB1B MPHOSPH9	1.54e-04	194	134	7	1715_DN
Drug	Buflomedil hydrochloride [35543-24-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A	NEBL HIRA NCOR1 SCAPER TLN2 CEP152 ATM	1.54e-04	194	134	7	3274_DN
Drug	Guaifenesin [93-14-1]; Down 200; 20.2uM; MCF7; HT_HG-U133A	USP34 MAP7D3 HIRA NF1 KCNJ3 CEP152 ATM	1.54e-04	194	134	7	3431_DN
Drug	Domperidone maleate; Up 200; 7.4uM; MCF7; HT_HG-U133A	COL5A2 SYNE1 CASP10 HUWE1 TRANK1 NKTR SLC24A1	1.54e-04	194	134	7	5701_UP
Drug	Mifepristone [84371-65-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A	ZBTB6 NEBL HIRA NCOR1 NF1 KCNJ3 NKTR	1.59e-04	195	134	7	3185_DN
Drug	Fluspirilen [1841-19-6]; Down 200; 8.4uM; PC3; HT_HG-U133A	NEBL RGS5 SYNE1 NCOR1 NF1 TLN2 NKTR	1.59e-04	195	134	7	6662_DN
Drug	Tiaprofenic acid [33005-95-7]; Down 200; 15.4uM; MCF7; HT_HG-U133A	PPFIBP1 ITSN1 ADGRL1 NF1 ZNF277 METTL16 EXOC7	1.59e-04	195	134	7	2852_DN
Drug	Testosterone propionate [57-85-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A	NEBL MYO9B CYRIB HIRA NF1 KCNJ3 ATM	1.59e-04	195	134	7	2649_DN
Drug	Amiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; PC3; HT_HG-U133A	ZBTB6 MYO9B PHLDB1 NF1 KCNJ3 TLN2 EXOC7	1.64e-04	196	134	7	4000_UP
Drug	Chrysene-1,4-quinone [100900-16-1]; Down 200; 15.4uM; PC3; HT_HG-U133A	NCOR1 SLF2 LPAR6 SVIL NKTR ATM ESPL1	1.64e-04	196	134	7	7139_DN
Drug	Heliotrine [303-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A	MYO9B ECPAS HIRA NF1 NKTR ATM IQCG	1.64e-04	196	134	7	4739_DN
Drug	haloperidol; Up 200; 10uM; PC3; HT_HG-U133A	RGS5 DOCK9 TEX15 TLN2 CEP152 ATM CDON	1.64e-04	196	134	7	4468_UP
Drug	Naloxone hydrochloride [357-08-4]; Up 200; 11uM; MCF7; HT_HG-U133A	CASP10 TEX15 HUWE1 PHLDB1 ZNF277 PLCL2 KIF5A	1.64e-04	196	134	7	5606_UP
Drug	Mephenytoin [50-12-4]; Up 200; 18.4uM; PC3; HT_HG-U133A	MAP7D3 NEBL RGS5 CASP10 KCNJ3 PLCL2 CEP152	1.64e-04	196	134	7	5801_UP
Drug	Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; PC3; HT_HG-U133A	ITSN1 CYRIB HIRA TLN2 CEP152 ATM EXOC7	1.64e-04	196	134	7	2119_DN
Drug	Cyclopentolate hydrochloride [5870-29-1]; Down 200; 12.2uM; PC3; HT_HG-U133A	ITSN1 HIRA PHLDB1 NF1 SCAPER TLN2 ATM	1.64e-04	196	134	7	5734_DN
Drug	Prednisolone [50-24-8]; Down 200; 11uM; MCF7; HT_HG-U133A	HIRA YEATS2 PHLDB1 NF1 PAN2 MPHOSPH9 SLC24A1	1.64e-04	196	134	7	7424_DN
Drug	Flumequine [42835-25-6]; Up 200; 15.4uM; MCF7; HT_HG-U133A	ZBTB6 MYO9B DOCK9 ADGRL1 NF1 SLC24A1 ATP2B2	1.70e-04	197	134	7	5529_UP
Drug	Suprofen [40828-46-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A	NCOR1 PHLDB1 NF1 NFRKB SCAPER EXOC6B ATM	1.70e-04	197	134	7	3343_DN
Drug	Meticrane [1084-65-7]; Down 200; 14.6uM; MCF7; HT_HG-U133A	NEBL ITSN1 ADGRL1 CYRIB HIRA PTPN12 EXOC7	1.70e-04	197	134	7	1671_DN
Drug	Hymecromone [90-33-5]; Up 200; 22.8uM; MCF7; HT_HG-U133A	COL5A2 RGS5 USP29 HUWE1 NF1 KIF5A ATP2B2	1.70e-04	197	134	7	5684_UP
Drug	Conessine [546-06-5]; Down 200; 11.2uM; MCF7; HT_HG-U133A	ANK3 NEBL DOCK9 ADGRL1 ZNF277 KCNJ3 EXOC7	1.70e-04	197	134	7	4777_DN
Drug	sodium 4-phenylbutyrate; Up 200; 100uM; MCF7; HG-U133A	ADGRL1 CYRIB C2CD2L NF1 ARAP3 ZNF638 EXOC7	1.70e-04	197	134	7	341_UP
Drug	Fluorocurarine chloride [22273-09-2]; Up 200; 11.6uM; PC3; HT_HG-U133A	RGS5 SYNE1 DOCK9 USP29 NF1 PLCL2 SLC24A1	1.70e-04	197	134	7	5741_UP
Drug	Saquinavir mesylate [149845-06-7]; Down 200; 5.2uM; PC3; HT_HG-U133A	USP34 ZBTB6 MYO9B CYRIB HIRA SCAPER CEP152	1.70e-04	197	134	7	5770_DN
Drug	Fluorometholone [426-13-1]; Down 200; 10.6uM; PC3; HT_HG-U133A	COL5A2 ANK3 HIRA NF1 LPAR6 EXOC6B ATM	1.70e-04	197	134	7	5771_DN
Drug	Praziquantel [55268-74-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A	MYO9B DOCK9 ECPAS NF1 EXOC6B TLN2 EXOC7	1.70e-04	197	134	7	3189_DN
Drug	Minaprine dihydrochloride [25953-17-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A	NEBL PPFIBP1 CYRIB NCOR1 ZFHX3 ATM EXOC7	1.70e-04	197	134	7	1468_DN
Drug	Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A	COL5A2 TEX2 ADGRL1 HIRA YEATS2 EXOC7 SLC24A1	1.70e-04	197	134	7	2766_UP
Drug	Deferoxamine mesylate [138-14-7]; Up 200; 6uM; MCF7; HT_HG-U133A	VPS13C GCKR TEX15 SCAPER EXOC6B KIF5A ATP2B2	1.75e-04	198	134	7	3842_UP
Drug	Flavoxate hydrochloride [3717-88-2]; Up 200; 9.4uM; HL60; HT_HG-U133A	ANK3 NEBL USP29 KCNJ3 LPAR6 SCAPER ATP2B2	1.75e-04	198	134	7	2373_UP
Drug	Tacrine hydrochloride hydrate [1684-40-8]; Down 200; 15.8uM; MCF7; HT_HG-U133A	HIRA C2CD2L KCNJ3 NFRKB ATM EXOC7 SLC24A1	1.75e-04	198	134	7	2633_DN
Drug	5149715; Down 200; 10uM; MCF7; HT_HG-U133A_EA	USP34 MYO9B CYRIB YEATS2 NF1 CEP152 NKTR	1.75e-04	198	134	7	890_DN
Drug	Cortisone [53-06-5]; Down 200; 11uM; MCF7; HT_HG-U133A	VPS13C ITSN1 ADGRL1 HMGCL NF1 KCNJ3 EXOC7	1.75e-04	198	134	7	7416_DN
Drug	Famotidine [76824-35-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A	VPS13C ITSN1 HIRA CEP152 ATM EXOC7 CDON	1.75e-04	198	134	7	1529_UP
Drug	Bemegride [64-65-3]; Down 200; 25.8uM; PC3; HT_HG-U133A	RGS5 SYNE1 DOCK9 NF1 ZNF277 TLN2 IQCG	1.75e-04	198	134	7	6668_DN
Drug	Triflusal [322-79-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A	RGS5 ITSN1 CASP10 ECPAS NF1 TLN2 CDON	1.75e-04	198	134	7	2867_UP
Drug	Oxybutynin chloride [1508-65-2]; Up 200; 10.2uM; PC3; HT_HG-U133A	ADGRL1 CHD9 C2CD2L NF1 SCAPER ZFHX3 FAM131B	1.75e-04	198	134	7	7126_UP
Drug	Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; HL60; HT_HG-U133A	MYO9B HIRA NCOR1 NF1 SVIL SCAPER CEP152	1.75e-04	198	134	7	2364_DN
Drug	Phensuximide [86-34-0]; Up 200; 21.2uM; MCF7; HT_HG-U133A	COL5A2 HBS1L MYO9B NF1 KIF5A EXOC7 RBFA	1.75e-04	198	134	7	5522_UP
Drug	Pridinol methanesulfonate salt [6856-31-1]; Up 200; 10.2uM; HL60; HT_HG-U133A	USP34 NEBL VPS13C USP29 CASP10 PHLDB1 PLCL2	1.75e-04	198	134	7	2715_UP
Drug	Dichlorphenamide [120-97-8]; Down 200; 13.2uM; MCF7; HT_HG-U133A	PPFIBP1 ADGRL1 CYRIB C2CD2L UBE2O NF1 EXOC7	1.75e-04	198	134	7	5286_DN
Drug	Fluocinonide [356-12-7]; Down 200; 8uM; PC3; HT_HG-U133A	COL5A2 ZBTB6 MAP7D3 PPFIBP1 ECPAS HIRA NFRKB	1.75e-04	198	134	7	3757_DN
Drug	Biotin [58-85-5]; Up 200; 16.4uM; PC3; HT_HG-U133A	NEBL DOCK9 CASP10 SCAPER CEP152 SLC24A1 ATP2B2	1.75e-04	198	134	7	6689_UP
Drug	Dipyridamole [58-32-2]; Up 200; 8uM; MCF7; HT_HG-U133A	DOCK9 CASP10 TEX15 CNTLN PHLDB1 DMD SLC24A1	1.75e-04	198	134	7	5617_UP
Drug	Nifedipine [21829-25-4]; Down 200; 11.6uM; PC3; HT_HG-U133A	MYO9B ITSN1 HIRA MED24 PHLDB1 FAM131B CDON	1.75e-04	198	134	7	7303_DN
Drug	Etofylline [519-37-9]; Up 200; 17.8uM; PC3; HT_HG-U133A	NEBL MYO9B DOCK9 CYRIB NF1 PLCL2 NFRKB	1.81e-04	199	134	7	5048_UP
Drug	Reserpine [50-55-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A	PPFIBP1 HIRA PHLDB1 NF1 KCNJ3 TLN2 ATM	1.81e-04	199	134	7	3341_DN
Drug	Medrysone [2668-66-8]; Up 200; 11.6uM; MCF7; HT_HG-U133A	AOC1 CASP10 TEX15 HUWE1 KIF5A ATP2B2 CDON	1.81e-04	199	134	7	3603_UP
Drug	Nicergoline; Down 200; 8.2uM; MCF7; HT_HG-U133A	HBS1L MYO9B CYRIB HIRA PHLDB1 MPHOSPH9 CDON	1.81e-04	199	134	7	2220_DN
Drug	chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A	USP34 ANK3 ITSN1 NF1 KCNJ3 SVIL ZFHX3	1.81e-04	199	134	7	6936_DN
Drug	Procyclidine hydrochloride [1508-76-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A	DOCK9 HIRA PTPN12 KCNJ3 NKTR ATM METTL16	1.81e-04	199	134	7	4817_DN
Drug	Dipivefrin hydrochloride [64019-93-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A	ZBTB6 ADGRL1 CYRIB HIRA SCAPER ATM EXOC7	1.81e-04	199	134	7	2744_DN
Drug	Benoxinate hydrochloride [5987-82-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A	MAP7D3 ANK3 NEBL PTPN12 ZFHX3 ATM RBFA	1.86e-04	200	134	7	1476_DN
Drug	Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; PC3; HT_HG-U133A	ZBTB6 DOCK9 CYRIB NF1 ZNF277 NKTR IQCG	1.86e-04	200	134	7	6679_DN
Drug	Hydroxyzine dihydrochloride [2192-20-3]; Up 200; 9uM; MCF7; HT_HG-U133A	USP34 HBS1L ITSN1 NF1 SCAPER CEP152 SLC24A1	1.86e-04	200	134	7	1524_UP
Drug	Palmatine chloride [3486-67-7]; Down 200; 10.4uM; PC3; HT_HG-U133A	NEBL SYNE1 ADGRL1 NF1 ZNF277 NFRKB CDON	1.86e-04	200	134	7	6612_DN
Disease	blood urea nitrogen measurement	ZNF704 DOCK9 CHD9 GCKR ZNF462 CDKL5 PHLDB1 SLF2 BUB1B DMD ASCC3	5.47e-06	452	130	11	EFO_0004741
Disease	Colorectal Carcinoma	SYNE1 CDKL5 SLC22A9 CYREN NF1 ARAP3 ABCA6 CCNB3 BUB1B MKI67 PAN2 DMD	6.69e-05	702	130	12	C0009402
Disease	creatinine measurement	KIF26B SNX17 CHD9 GCKR LACTB C2CD2L CDKL5 PTPN12 SLF2 SVIL CPNE3 ZFHX3 PNPLA7 ASCC3	1.30e-04	995	130	14	EFO_0004518
Disease	QRS duration, response to sulfonylurea	DOCK9 CNTLN ZNF638	1.39e-04	23	130	3	EFO_0005055, EFO_0007922
Disease	fasting blood glucose measurement, glucose tolerance test, fasting blood insulin measurement	VPS13C GCKR	1.91e-04	5	130	2	EFO_0004307, EFO_0004465, EFO_0004466
Disease	coagulation factor IXAB measurement	SNX17 GCKR	1.91e-04	5	130	2	EFO_0020264
Disease	breast size	VPS13C SNX17 GCKR CDON	2.49e-04	69	130	4	EFO_0004884
Disease	level of Phosphatidylcholine (16:0_16:1) in blood serum	SNX17 GCKR	2.86e-04	6	130	2	OBA_2045068
Disease	cortical surface area measurement	USP34 COL5A2 PRTG ANK3 MYO9B KIF26B PPFIBP1 DOCK9 PARD3B CNTLN ITIH5 NCOR1 EXOC6B TLN2 ZFHX3 MPHOSPH9	2.89e-04	1345	130	16	EFO_0010736
Disease	bitter alcoholic beverage consumption measurement	GCKR ADH7 NF1 SCAPER ZFHX3	3.15e-04	133	130	5	EFO_0010092
Disease	platelet reactivity measurement, thrombus formation measurement	RGS5 SVIL	3.99e-04	7	130	2	EFO_0004985, EFO_0007615
Disease	cerebellar ataxia (implicated_via_orthology)	VPS13C PNPLA7	5.30e-04	8	130	2	DOID:0050753 (implicated_via_orthology)
Disease	Embryonal Rhabdomyosarcoma	BUB1B DMD	5.30e-04	8	130	2	C0206656
Disease	sick sinus syndrome	CCDC141 ZFHX3	5.30e-04	8	130	2	MONDO_0001823
Disease	familial sick sinus syndrome	CCDC141 ZFHX3	5.30e-04	8	130	2	MONDO_0012061
Disease	level of Triacylglycerol (49:2) in blood serum	SNX17 GCKR	5.30e-04	8	130	2	OBA_2045162
Disease	alkaline phosphatase measurement	USP34 AOC1 SNX17 GCKR ADH7 MED24 PRR14 PHLDB1 TRANK1 NF1 ABCA6 SLF2 MYLK4	5.59e-04	1015	130	13	EFO_0004533
Disease	familial Mediterranean fever (is_implicated_in)	POMC MEFV	6.80e-04	9	130	2	DOID:2987 (is_implicated_in)
Disease	Intellectual Disability	MAP7D3 SYNE1 HMGCL ZNF462 NF1 SCAPER KIF5A ASCC3	8.47e-04	447	130	8	C3714756
Disease	gamma-glutamylthreonine measurement	GCKR CNTLN	8.47e-04	10	130	2	EFO_0021143
Disease	level of Triacylglycerol (51:3) in blood serum	SNX17 GCKR	8.47e-04	10	130	2	OBA_2045163
Disease	metabolite measurement	AOC1 ANK3 SLC17A3 GCKR LACTB ZNF462 SLC22A9 CLVS2 DMD	8.66e-04	560	130	9	EFO_0004725
Disease	alpha fetoprotein measurement	USP34 CHD9 GCKR NCOR1	1.02e-03	100	130	4	EFO_0010583
Disease	Adenoid Cystic Carcinoma	CNTN6 ATM ESPL1 SON	1.02e-03	100	130	4	C0010606
Disease	cleft lip	PRTG SYNE1 MUC16 CCDC168 ADH7 SVIL	1.66e-03	284	130	6	EFO_0003959
Disease	level of Phosphatidylethanolamine (18:2_0:0) in blood serum	SNX17 GCKR	1.69e-03	14	130	2	OBA_2045143
Disease	leukemia	NF1 ATM GSTO1	1.85e-03	55	130	3	C0023418
Disease	factor VII measurement	PRTG GCKR ADH7	1.85e-03	55	130	3	EFO_0004619
Disease	triacylglycerol 52:3 measurement	SNX17 GCKR	1.95e-03	15	130	2	EFO_0010415
Disease	level of Triacylglycerol (53:3) in blood serum	SNX17 GCKR	1.95e-03	15	130	2	OBA_2045165
Disease	colorectal cancer (is_implicated_in)	PTPN12 BUB1B MKI67 ATM	2.05e-03	121	130	4	DOID:9256 (is_implicated_in)
Disease	triacylglycerol 50:5 measurement	SNX17 GCKR	2.22e-03	16	130	2	EFO_0010412
Disease	puberty onset measurement	GCKR ECPAS SLF2 TMEM102	2.31e-03	125	130	4	EFO_0005677
Disease	Benign neoplasm of stomach	CASP10 ATM	2.51e-03	17	130	2	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	CASP10 ATM	2.51e-03	17	130	2	C0496905
Disease	Carcinoma in situ of stomach	CASP10 ATM	2.51e-03	17	130	2	C0154060
Disease	level of Phosphatidylcholine (14:0_18:2) in blood serum	SNX17 GCKR	2.51e-03	17	130	2	OBA_2045063
Disease	sphingosine 1-phosphate measurement	UBE2O DMD	2.81e-03	18	130	2	EFO_0800185
Disease	serum metabolite measurement	AOC1 SLC17A3 KIF26B PARD3B GCKR LACTB ADH7 EXOC6B TLN2 ZFHX3 FOXF2	3.14e-03	945	130	11	EFO_0005653
Disease	gastric ulcer	MYO9B PLCL2	3.83e-03	21	130	2	EFO_0009454
Disease	Stomach Carcinoma	CASP10 ATM	3.83e-03	21	130	2	C0699791
Disease	Manic Disorder	ANK3 POMC TRANK1	3.84e-03	71	130	3	C0024713
Disease	testosterone measurement	ZNF704 AOC1 ANK3 SLC17A3 RGS5 MYO9B GCKR NF1 ZFHX3 TMEM102 METTL16 SLC24A1 ATP2B2	4.19e-03	1275	130	13	EFO_0004908
Disease	triacylglycerol 48:2 measurement	SNX17 GCKR	4.20e-03	22	130	2	EFO_0010405
Disease	triacylglycerol 48:3 measurement	SNX17 GCKR	4.20e-03	22	130	2	EFO_0010406

Protein segments in the cluster

Peptide	Gene	Start	Entry
TMPTKETTKLQIASE	BUB1B	471	O60566
KDSTKPISEVLSEMT	ADH7	256	P40394
KLATMAKLLETPISS	CEP152	1341	O94986
VIPLTAIEMTRSSKD	ARAP3	331	Q8WWN8
RPSLSSLETLMVSQK	CNTLN	451	Q9NXG0
LHKMIRSSSVLKPDS	ADGRL1	1026	O94910
SVTAITMKTLPFITK	ABCA6	201	Q8N139
SRVTLLETEMLLSKK	CEP44	281	Q9C0F1
TTMTKLKEASRSSPV	CPNE3	231	O75131
TKETAISKLEMPSSL	DMD	2451	P11532
KTKEPVIMSTLETVR	DMD	2856	P11532
KKELRLQPSSTTTMA	AOC1	51	P19801
LLTETSDLKTKMATL	CCDC157	346	Q569K6
RKSMSTVIKLPDESF	ATP2B2	606	Q01814
MEKPLILDISTTSKT	CCNB3	131	Q8WWL7
ITSGEKSLIMKPLSI	CCNB3	406	Q8WWL7
FKKPTRQTIMTTETL	IQCG	151	Q9H095
TSSKMLRVKLTVAPD	NKD1	176	Q969G9
PSKLEFLMRSTSKKT	RBFA	71	Q8N0V3
TSRSESEIVPKVAKM	HBS1L	151	Q9Y450
METLQSETKTRVLPS	CYREN	1	Q9BWK5
KSKLSLTPGLMETSI	MUC16	9281	Q8WXI7
SMETITRISTPLTRK	MUC16	9346	Q8WXI7
TRISTPLTRKESTDM	MUC16	9351	Q8WXI7
LRSDGTKSTIKPSQM	PAN2	991	Q504Q3
ELLTSPRTKDTLSDM	PARD3B	186	Q8TEW8
MATKTELSPTARESK	SLC17A3	1	O00476
SILTSKPACMLTRKE	MKKS	156	Q9NPJ1
VPTLSTTDMKTADKV	NFRKB	236	Q6P4R8
SLKRIMEETTPTTLK	SLC24A1	236	O60721
MKEDPTVSALLTSEK	GSTO1	206	P78417
KTKPLMTEFSVKSTI	ITIH5	46	Q86UX2
TVSMETSEKSKLTPK	PPFIBP1	416	Q86W92
PSESKKEILSTTMVT	KIF26B	1161	Q2KJY2
ISRSTTPDLIKIGMK	KIAA1109	4561	Q2LD37
PETVMRIASISKSLT	LACTB	156	P83111
TSILKEMLKDISSVP	FSIP2	1111	Q5CZC0
SRIPSSKETNKMKER	ECPAS	846	Q5VYK3
EATQKLSSPIDMTSK	NFIL3	346	Q16649
MTSEKSQTPLVTLFK	POMC	241	P01189
NRKSSTPTKREIMLT	MPHOSPH9	811	Q99550
ADLTERMPVKSKRTS	MYLK4	61	Q86YV6
MKELSLKASPLRSET	METTL16	321	Q86W50
LEKTRAELKTAMSTP	MSN	456	P26038
MVLKTLTKPVTLSRS	LPAR6	206	P43657
KTSISRKGNMTLSPE	MEFV	671	O15553
PVTALTLLEKMKDTS	EXOC6B	761	Q9Y2D4
PSLKSRVTMSVDTSK	IGHV4-28	81	A0A0C4DH34
MKEEPLAVSKLTRTS	MKI67	2491	P46013
SSEPVVIMKRSLRTS	MKI67	3041	P46013
RSMELKTVKPIDTSK	NDST4	61	Q9H3R1
KISESPSEIMESLTK	HUWE1	231	Q7Z6Z7
MSPKADVKLKTSRVT	KIAA1328	46	Q86T90
SKSRKSVMVAEIPST	PNPLA7	416	Q6ZV29
LSMEDTTSILPKLKR	FAM131B	31	Q86XD5
STKNKLPGLITSMET	EXOC7	456	Q9UPT5
SKKLLSLSSTVVTPM	OR10A4	271	Q9H209
SMEASLTVIPAKESK	PRTG	216	Q2VWP7
PKIATLMKSVSTSLE	GCKR	311	Q14397
KLLMLIDSSTLEPTK	ATM	926	Q13315
LSSRTVKKEISPGVM	CHD9	696	Q3L8U1
MRTITPSLVDELKAS	HTRA3	361	P83110
IKASAVLSKSMEAPS	ESPL1	316	Q14674
KRISKTLNMTTSPEE	GMPS	321	P49915
MVPREEIKSTSAKSS	CCDC141	1386	Q6ZP82
LTKSMTTILKPSADF	DOCK9	936	Q9BZ29
SITPTKKIELDRTIM	C2CD2L	426	O14523
IVTSPESVKKFLMST	CYP46A1	86	Q9Y6A2
TIKTKLPVTLRSMSL	COG3	756	Q96JB2
SQKKSLMSTSEVLEP	CMYA5	1511	Q8N3K9
SKQSTEAESIRKRPM	CRACD	736	Q6ZU35
VKLISGPIRKSTSMD	ITSN1	966	Q15811
PAMLTFRTSKEKTAS	CDON	666	Q4KMG0
MSTETLKLRRKETST	CCDC183	276	Q5T5S1
GSLSEIKEMTVKSPS	ANK3	2911	Q12955
TLKSLSSQIETMRSP	COL5A2	1271	P05997
SEEIRIPKMSSLSSR	CNTN6	986	Q9UQ52
PEKNTESLILSLKMS	C17orf80	271	Q9BSJ5
VKASPKTSLEASMEA	MAP7D3	446	Q8IWC1
TTRVKKSAEMEPEDS	KIF5A	806	Q12840
FLLKDSLPKTEMTSL	CASP10	136	Q92851
PMLKTLSDATTKFVS	CYRIB	196	Q9NUQ9
LKVSTVTSPSRMIRK	AHCTF1	1891	Q8WYP5
EKSPNTSEMSKRDTL	CCDC168	6176	Q8NDH2
ALTSMTPTAVERLKE	HIRA	581	P54198
TTRHSKTMEELKLPE	CDKL5	561	O76039
VMPKVSLATEATRSK	SCAPER	281	Q9BY12
SPTKTLSVKSILSAM	GARNL3	156	Q5VVW2
MAIQSSPSKRLTLSE	FOXF2	111	Q12947
ESLSDMVVPRSTKLI	ATP6V1C2	201	Q8NEY4
TTLIAPRIESKSMSA	SNX2	106	O60749
MSTKTTSILKLPTKA	SLITRK6	296	Q9H5Y7
GLLDSPSKTMSIKER	SVIL	1116	O95425
STKMEAIELKLSESP	SYNE1	5976	Q8NF91
SVLKSLPFTIISMKD	DNTT	196	P04053
IPSDIESSKSSTRRM	NKTR	461	P30414
KDITMKNLVEPSLSS	RGS5	136	O15539
ARDTLTLEILKSTMK	SLC22A9	311	Q8IVM8
SLEISLSPMTVKKDI	ODAD2	191	Q5T2S8
VSTSSMGTLPKRVKI	HMGCL	21	P35914
ASPSKLSKEELIQSM	NCOR1	171	O75376
RERKKTVSFSSMPTE	PLCL2	116	Q9UPR0
VLSEPETKTMGKVSR	PRR14	431	Q9BWN1
TVSELVKVSAMSSPK	MED24	951	O75448
STESISTRKVLPMSI	PTPN12	636	Q05209
VDSDLKSTRESMIPK	SLF2	341	Q8IX21
SKSEILRTQMLVTTP	ASCC3	571	Q8N3C0
ELSPKSMKRSQSVVD	CLVS2	291	Q5SYC1
SPDATRESMVKLSSK	SNX17	421	Q15036
APMTEIKKLTSSTDR	ZNF320	111	A2RRD8
LTETKSMIFSPASKV	STIM2	656	Q9P246
PLKTMSSDVTKAAVE	TMEM102	231	Q8N9M5
STVRKEMALLATSLP	UBE2O	956	Q9C0C9
MKLTSESSDSLVLPV	USP29	581	Q9HBJ7
RMAPSLTFKEKVTSL	NF1	461	P21359
TVLTIMAALSPKTKE	VPS13C	2211	Q709C8
TTSTLKEMEKLLLPA	PHLDB1	906	Q86UU1
ELRISAKLSTVKTMS	ZC3H12B	391	Q5HYM0
MSKVSFKITLTSDPR	UFM1	1	P61960
AKTETKLMTPLSRSA	ZNF704	281	Q6ZNC4
MEETKHTSLLPDRKT	ZNF277	376	Q9NRM2
KTPTSLNIRDFTMEK	ZNF548	516	Q8NEK5
TMLEESVSPKKSTIL	TLN2	421	Q9Y4G6
RSILESMVKPLTKSR	ZNF462	226	Q96JM2
IEMKKRSPISTDTSL	SCN7A	436	Q01118
ISAKPLEMSSEAKAT	STARD7	336	Q9NQZ5
DPKAVSLMTAKLSTS	USP34	2296	Q70CQ2
TVTTSKSIKDPRLMR	TEX15	41	Q9BXT5
EEMLKTKTLPISKLS	TRANK1	1846	O15050
KPFMSLVKSLSTEVE	TEX2	186	Q8IWB9
VATMTSEEKKERPIS	PLEKHA5	106	Q9HAU0
QMKSVLKSVESTSPE	SON	271	P18583
RMTTTKSPSKDMLEP	XRRA1	471	Q6P2D8
TMIERHLTAKTPTKR	ZNF638	1841	Q14966
LMKISDSTLKTVPAT	YEATS2	921	Q9ULM3
KTTPTLMSLEELKEA	UBASH3A	521	P57075
TPTSTMNTLKRKLEE	ZFHX3	2606	Q15911
ESLTSERKEMKSPEL	ZBTB6	191	Q15916
PLSETLISKMEATAR	GARIN5B	831	Q8N5Q1
DFPKKLLRMSSTTSE	KCNJ3	411	P48549
SDPLTSMKDVLKITT	MYO9B	1861	Q13459
ATTLSVTPEMERVKK	NEBL	726	O76041